| 211K |
| $211K |
| +33.8% |
| 1.028% |
| 0.00% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 196K | $196K | -8.5% | 0.954% | 0.00% |
| 5 | VANGUARD FIDUCIARY TRUST CO | 84K | $84K | 0.0% | 0.410% | 0.00% |
| 6 | STATE STREET CORP | 64K | $64K | 0.0% | 0.311% | 0.00% |
| 7 | LPL Financial LLC | 41K | $41K | — | 0.200% | 0.00% |
| 8 | NORTHERN TRUST CORP | 39K | $39K | -7.9% | 0.189% | 0.00% |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 26K | $26K | — | 0.126% | 0.00% |
| 10 | Lido Advisors, LLC | 20K | $20K | -50.0% | 0.095% | 0.00% |
| 11 | MORGAN STANLEY | 10K | $10K | 0.0% | 0.049% | 0.00% |
| 12 | Charles Schwab Trust Co | 10K | $10K | — | 0.049% | 0.00% |
| 13 | SBI Securities Co., Ltd. | 5K | $5K | +40963.6% | 0.022% | 0.00% |
| 14 | Farther Finance Advisors, LLC | 4K | $4K | — | 0.021% | 0.00% |
| 15 | OSAIC HOLDINGS, INC. | 3K | $3K | 0.0% | 0.013% | 0.00% |
| 16 | Tower Research Capital LLC (TRC) | 2K | $2K | -72.7% | 0.010% | 0.00% |
| 17 | Federation des caisses Desjardins du Quebec | 350 | $343 | 0.0% | 0.002% | 0.00% |
| 18 | JONES FINANCIAL COMPANIES LLLP | 100 | $95 | -80.0% | 0.001% | 0.00% |
| 19 | MCGUIRE CAPITAL ADVISORS INC | 50 | $50 | — | 0.000% | 0.00% |
| 20 | IFP Advisors, Inc | 45 | $45 | 0.0% | 0.000% | 0.00% |
| 21 | Robinswood Financial LLC | 40 | $39 | 0.0% | 0.000% | 0.00% |
| 22 | ROYAL BANK OF CANADA | 240 | $0 | -72.4% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in RKTO — a direct measure of their conviction.
Institutions that fully closed their RKTO position in Q2 2026
| 5.74% |
| +3.90 pp |
| $1M |
| +238% |
| Q4 2024 | 15 | +7.1% | 1.84% | +0.24 pp | $0M | 2.2% |
| Q3 2024 | 14 | — | 1.60% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
6 institutions opened new positions in RKTO during Q2 2026, while 3 fully exited. 12 added to existing positions and 3 trimmed.
RKTO institutional ownership rose by 2.41 percentage points quarter-over-quarter, with a net change of +3 holders.
The top 10 institutions account for 97.9% of all reported 13F value in RKTO, and the top 25 account for 100.0%.
Across the largest Immunology Biotech peers, institutional ownership levels are: LKFT (49.6%), YARW (1.2%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.